Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475709 · ClinicalTrials.gov registry record · NA
Aortic Valve Replacement With Trifecta(TM)
A NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,022
- Enrollment target
- 18
- Study locations
NCT00475709: Completed NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency, sponsored by Abbott Medical Devices.
NCT00475709 is a NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,022 participants, roughly in line with the 1,009-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target. The trial reports 18 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00475709, a NA study of Aortic Valve Stenosis and Aortic Valve Insufficiency, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,022 participants
- Enrollment target
- 18
- Study locations
Study Summary
To confirm the clinical safety and effectiveness of the Trifecta valve.
Primary Outcome
Late patient years are calculated from 31 days post-implant to the date of the last follow-up visits (or contact) or adverse events. Late Patient year calculation:\[(Number of late adverse events/sum of late patient years) x 100\]
Conditions Studied
Interventions
- DEVICE Trifecta Aortic Heart Valve
Study Locations (18)
Minnesota
- Abbott Northwestern Hospital - Minneapolis
- Mayo Clinic - Rochester
New York
- NYU Medical Center - New York
- Columbia University Medical Center - New York
North Carolina
- Mission Hospitals - Asheville
- Duke University Medical Center - Durham
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
- Main Line Health Heart Center - Wynnewood
Texas
- Cardiothoracic and Vascular Surgeons - Austin
- Baylor College of Medicine - Houston
California
- USC Keck School of Medicine, Dept. of Cardiothoracic Surgery, USC University Hospital - Los Angeles
Florida
- Sarasota Memorial Hospital/Clinical Research Center - Sarasota
Illinois
- Loyola University Medical Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,022 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00475709 record still lists
NCT00475709 is an interventional study that assigns participants to a tested intervention. Its 1,022 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,009-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target.
The record links to 4 conditions, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Trifecta Aortic Heart Valve is the first listed.
NCT00475709 lists 18 locations in 13 states (Minnesota, New York, North Carolina).
Frequently Asked Questions
What is clinical trial NCT00475709 about?
NCT00475709 is a clinical study titled "Aortic Valve Replacement With Trifecta(TM)". To confirm the clinical safety and effectiveness of the Trifecta valve.
What is the current status of trial NCT00475709?
This trial is currently completed. It is a NA study. The enrollment target is 1,022 participants. The study started on 2007-06. Estimated completion is 2012-01.
What conditions does trial NCT00475709 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis, Aortic Valve Insufficiency, Regurgitation, Aortic Valve, Aortic Valve Incompetence.
What interventions are being tested in trial NCT00475709?
The interventions under investigation include: Trifecta Aortic Heart Valve (DEVICE).
Who is sponsoring clinical trial NCT00475709?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00475709 being conducted?
This trial has 18 study locations across California, Florida, Illinois, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00475709's enrollment target sits among peer trials
1,022 8th of 30 higher than 23 of 30 other Aortic Valve Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Valve Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07216703 · 1,023 participants · Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia